Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) announced that it now plans to present initial single ascending dose (SAD) cohort data from its ALN-AS1 Phase 1 study in ASHE patients at the International Congress of Porphyrins and Porphyrias (ICPP) 2015, being held September 14 – 16, 2015 in Düsseldorf, Germany, in an oral presentation on Tuesday, September 15. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) belongs to Healthcare sector. Its weekly performance is -16.67%. On last trading day company shares ended up $106.19. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) distance from 50-day simple moving average (SMA50) is -16.61%.
EMC Corporation (NYSE:EMC) has declared a quarterly cash dividend of $0.115 per common share. The dividend will be payable on October 23, 2015 to shareholders of record as of October 1, 2015. EMC Corporation (NYSE:EMC) shares moved up 0.11% in last trading session and ended the day at $27.24. EMC Gross Margin is 62.00% and its return on assets is 6.60%. EMC Corporation (NYSE:EMC) quarterly performance is 1.59%.
On 29 July, MedAssets, Inc. (NASDAQ:MDAS) reported Total net revenue for the second quarter of 2015 increased 8.6% to $190.4 million from $175.4 million for the second quarter of 2014. Excluding the revenue contribution from Sg2 (acquired on September 22, 2014), total net revenue growth was 1.8% on a year-over-year basis.On 07 August, MedAssets, Inc. (NASDAQ:MDAS) shares fell -1.67% and was closed at $20.59. MDAS EPS growth in last 5 year was -24.60%. MedAssets, Inc. (NASDAQ:MDAS) year to date (YTD) performance is 4.20%.
Global Hunter Securities started coverage on shares of HB Fuller (NYSE:FUL) in a research report sent to investors on Tuesday morning, MarketBeat reports. The firm issued an accumulate rating and a $48.00 price target on the stock. HB Fuller Co. (NYSE:FUL) ended the last trading day at $39.54. Company weekly volatility is calculated as 1.72% and price to cash ratio as 25.12. HB Fuller Co. (NYSE:FUL) showed a weekly performance of -1.30%.
On 5 August, Cutera Inc. (NASDAQ:CUTR) reported a loss of $1.9 million in its second quarter. On a per-share basis, the Brisbane, California-based company said it had a loss of 13 cents. Losses, adjusted for non-recurring costs and stock option expense, came to 4 cents per share. The maker of laser skin treatments posted revenue of $22.6 million in the period.Cutera, Inc. (NASDAQ:CUTR) shares fell -1.21% in last trading session and ended the day at $14.72. CUTR Gross Margin is 54.90% and its return on assets is -9.90%. Cutera, Inc. (NASDAQ:CUTR) quarterly performance is 1.24%.